Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02827968
Title Phase 1 Study of Anti-PD-L1 Monoclonal Antibody KN035 to Treat Locally Advanced or Metastatic Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors 3D Medicines (Sichuan) Co., Ltd.
Indications

Advanced Solid Tumor

Therapies

Envafolimab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.